Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on November 7, 2017. The filing documents the completion of a previously announced management transition effective as of the report date.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a corporate governance report regarding executive changes.
Material Changes
- Departure of Executive Officer and Director: Francis (Frank) P. Grillo voluntarily resigned as Chief Executive Officer, President, and member of the Board of Directors. The resignation was not due to any disagreement with the Company.
- Appointment of Executive Officer: Joseph Michael Burnett was appointed as the new Chief Executive Officer and President, replacing Mr. Grillo.
- Election of Director: Joseph Michael Burnett was elected to the Board of Directors to serve until the 2018 annual meeting of stockholders.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of market risks. It references a Separation, Transition and Consulting Agreement for Mr. Grillo and an Employment Agreement for Mr. Burnett, the terms of which were previously disclosed in an October 10, 2017, Form 8-K.
Investor Verification Checklist
- Verify the terms of the Separation, Transition and Consulting Agreement (Exhibit 10.1 to the October 10, 2017 filing) to understand Mr. Grillo's compensation upon departure.
- Review the Employment Agreement for Joseph Michael Burnett (Exhibit 10.2 to the October 10, 2017 filing) for details on his compensation and tenure.
- Confirm the status of the Board of Directors following Mr. Grillo's resignation and Mr. Burnett's election.